Evidence map›Paper›PMID 30988557›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2019

T Regulatory Cells in Donor Grafts May Predict the Severity of Acute Graft Versus Host Disease After Matched Sibling Donor Allogenic Peripheral Blood Stem Cell Transplantation.

Dinesh Chandra, Jasdeep Singh, Roopam Deka, Ankur Ahuja, Rahul Sharma, Pravas Mishra, Tulika Seth, Manoranjan Mahapatra, Lalit Kumar, Seema Tyagi and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Dinesh Chandra1Department of Hematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Jasdeep Singh2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Roopam Deka2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Ankur Ahuja2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Rahul Sharma2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Pravas Mishra2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Tulika Seth2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Manoranjan Mahapatra2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Lalit Kumar3Medical Oncology, IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Seema Tyagi2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Renu Saxena2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
Hara Prasad Pati2Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029 India.
All India Institute of Medical Sciences · INSanjay Gandhi Post Graduate Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute graft-versus-host disease (aGVHD) and relapse are major issues for patients undergoing allogenic hematopoietic stem cell transplant (allo-HSCT). T-regulatory (Treg) cells in the donor graft are negatively correlated with the incidence of aGVHD without any impact on relapse. In this study to determine the association of Treg cells with aGVHD in allo-HSCT patients. Thirty-two patients with hematological disorders, who underwent allo-HSCT. Twenty-nine patients who achieved engraftment were enrolled in the study. Treg cells were quantified in donor graft by flowcytometry and were assessed for their association with aGVHD and other clinical outcomes. Fifteen of 29 patients developed aGVHD. According to the occurrence and severity of aGVHD, patients were divided into two groups: 20 (68.9%) patients with grade 0-I aGVHD and 9 (31.1%) patients with grade II-IV aGVHD. Treg cells/CD4 ratio was significantly higher in the grade 0-I aGVHD group than in grade II-IV aGVHD group, (

Indexed as

Acute GVHDAllo-HSCTT-regulatory cells

Identifiers

PMID30988557
PMCPMC6439099
OpenAlexW2909125909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.